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Objective : The purpose of this study was to report the authors' prelimi-
nary experience using the Amplatzer Vascular Plug (AVP) (St. Jude Medical, 
Plymouth, MN, USA) for parent artery occlusion of the internal carotid ar-
tery (ICA) or vertebral artery (VA).
Materials and Methods : Between September 2008 and December 2015, 
we performed 52 therapeutic parent artery occlusions (PAOs) by an en-
dovascular technique. Among them, 10 patients underwent PAO of the 
carotid or vertebral arteries using AVPs. Clinical and radiographic data of 
these patients were retrospectively reviewed.
Results : The devices were used for VA dissection that presented with 
subarachnoid hemorrhage (SAH) in five patients, traumatic arteriovenous 
fistula (AVF) in two patients, spontaneous AVF in one patient, recurrence 
of carotid-cavernous fistula (CCF) in one patient, and symptomatic unruptured 
giant ICA aneurysm in one patient. The devices were used in conjunction 
with detachable and/or pushable coils and in the extracranial segments 
of the ICA or VA. Complete occlusion of the parent artery was achieved in 
all patients. There was one intra-procedural rupture of the VA dissection 
during coiling prior to using the device.
Conclusion : Results from the current series suggest that the AVP might be 
used for therapeutic PAO in the extracranial segments of the ICA or VA.
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INTRODUCTION
Although reconstruction techniques using stents, such 
as flow-diverters, have come to the forefront in neuro-
endovascular fields, therapeutic parent artery occlusion 
(PAO) is still necessary in the treatment of fusiform giant 
cerebral aneurysms, arterial dissection, direct carotid-cav-
ernous fistula (CCF), or high-flow head and neck arte-
riovenous fistula (AVF). Historically, detachable bal-
loons were used for these purposes; however, after 
the balloon occlusion device was withdrawn from the 
market, coil embolization became the most common 
method for PAO.
The Amplatzer Vascular Plug (AVP) (St. Jude Medical, 
Plymouth, MN, USA) is a self-expanding nitinol mesh 
cage that was approved by the United States Food 
and Drug Administration for clinical use in 2004, for 
peripheral vascular embolizations. This device can serve 
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as an excellent alternative to coils or detachable bal-
loons in the embolization of medium to large vessels 
with high flow. The AVP family has developed and 
evolved from a single device to a group of 4 models 
(types 1 to 4) that can be used for various types of 
anatomy, hemodynamics, and lesion entities. All models 
contain two basic components: a vascular plug and a 
delivery wire. The plugs have radiopaque marker bands 
at both ends and a stainless-steel screw on one of the 
marker bands attaches to a delivery cable. Once the 
position of a deployed device is satisfactory, the de-
vice can easily be released by rotating the cable coun-
terclockwise to complete implantation. These days, 
the device has been successfully and extensively used 
in a wide range of therapeutic applications, even in 
neurovascular diseases.14) 
Relatively few reports about the use of these devices 
for applications in neuroendovascular fields have 
been published.6)8-11) The purpose of this study was to 
report the authors' preliminary experience in using 
AVPs for PAO of the internal carotid artery (ICA) or 
vertebral artery (VA).
MATERIALS AND METHODS
This retrospective study was approved by the in-
stitutional review board and the requirement for in-
formed consent was waived. Between September 2008 
and December 2015, we performed 52 therapeutic 
PAO surgeries by an endovascular technique. Among 
these, 10 patients underwent PAO of the ICA or VA 
using vascular plugs. The AVP has been used in the 
medium to large arteries (proximal ICA and VA) 
where simple coil occlusion wan not enough to oc-
clude the artery due to high flow. Clinical and radio-
graphic data of the patients, such as age, sex, initial 
presentation signs, laterality (right or left), location of 
the device deployed, number of devices used, type of 
the device, size of the device, number of detachable 
coils used, number of pushable coils used, proce-
dure-related complications, angiographic results, and 
clinical outcomes, were retrospectively reviewed and 
described.
All operations were performed under general anesthesia. 
A 6-Fr guiding catheter was positioned in the ICA 
and a 5-Fr or 6-Fr guiding catheter in the VA. Coil 
embolization was performed via a microcatheter with 
an inner diameter (ID) of 0.021 inches in cases using 
pushable coils. Similar to an intracranial self-expand-
ing stent, deployment of the AVP was performed by 
unsheathing the guiding catheter gently when it was 
correctly positioned. If the positioning of the device was 
suboptimal, it was re-sheathed and redeployed. The 
device was detached through counterclockwise rotation 
of the pusher wire using a torque device. Heparin 
was not injected intravenously or subcutaneously, but 
was instead mixed into the saline slushes during the 
procedure. Therefore, the activated clotting time (ACT) 
was not checked during the procedure. In addition, 
antiplatelet agents were not used.
The final angiographic results were evaluated by two 
independent investigators and categorized as com-
plete occlusion or incomplete occlusion of the parent 
arteries. There was no follow-up angiography at the 
time of analysis because we planned to perform fol-
low-up angiography when clinical symptoms or signs 
developed. There was no recurrence of clinical symp-
toms and signs. Clinical outcomes were assessed based 
on the modified Rankin Scale (mRS) in which a mRS 
score of 0 was completely independent and a mRS 
score of 6 was indicative of death.
RESULTS
Table 1 shows clinical and radiographic character-
istics of the patients. The device was used in addition 
to detachable and/or pushable coils in all 10 cases: 
five cases with intracranial VA dissection presented 
with subarachnoid hemorrhage (SAH); two cases with 
traumatic AVF; one case with spontaneous AVF; one 
case with recurrence of CCF; and one case with 
symptomatic unruptured giant ICA aneurysm. Mean 
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Fig. 1. (A) A 62-year-old female suffered from right side carotid-cavernous fistula (CCF) with complete steal and was treated by in-
ternal carotid artery (ICA) occlusion with coil embolization. (B) After right ICA occlusion, the collaterals from the anterior and posterior 
communicating artery supplied the right hemisphere. White circles indicate coils packed in the cavernous sinus and the right ICA. (C) 
Recanalization of the right ICA and the CCF occurred. (D) Retreatment by right ICA occlusion was performed with several additional 
coils and an Amplatzer Vascular Plug type 2.
age of the 10 patients was 55.6 years. A type 1 device 
was used only in the first case, type 2 devices were 
used in the next 6 cases, and type 4 devices were 
used most recently in 3 cases. Technical success rate 
was 100% and there were no cases of suboptimal de-
vice positioning in this study. There was one intra-
procedural rupture of the VA dissection during coil-
ing prior to using the device (case 4). Otherwise, there 
were no procedure-related complications related to 
use of the device. At discharge, mRS was 0 in six pa-
tients, 1 in two patients, 5 in one patient, and 6 (death 
due to an initial insert of SAH) in one patient.
Case illustrations
Case 2
A 62-year-old female suffered from right-side CCF 
with complete steal (Fig. 1A) and was treated by ICA 
occlusion with coil embolization. Immediate post-
operative right ICA angiography showed that com-
plete obliteration of the right ICA was achieved. In 
addition, the collaterals from the anterior and posteri-
or communicating artery supplied the right hemi-
sphere (Fig. 1B; white circles indicate coils packed in 
the cavernous sinus and the right ICA). However, re-
canalization of the right ICA and the CCF caused her 
to return to the institution (Fig. 1C). Retreatment by 
right ICA occlusion was performed with several addi-
tional coils and a type 2 AVP (Fig. 1D). Finally, com-
plete occlusion of the right ICA was achieved.
Case 10
A 38-year-old female with neurofibromatosis type I 
suffered from a large pulsatile mass on the left side 
of her neck. Her neck CT and digital subtraction cere-
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Fig. 2. A 38-year-old female with neurofibromatosis type I suffered from a large pulsatile mass on the left side of her neck. (A) 
Digital subtraction cerebral angiography revealed a very high-flow AVF from the V2 segment of the left VA to the cervical venous 
plexus with a large pseudoaneurysm or venous pouch just distal to the fistula. (B) Short-segment trapping of the left VA was 
performed. Two AVPs (type 4; white circles) were deployed distal and proximal to the fistula with coiling between the AVPs. (C , D) 
Final left VA angiography (C) and right VA angiography (D) revealed complete occlusion of the fistula (white circles indicate the 
AVPs and white arrow indicates the occlusion of retrograde flow). AVF = arteriovenous fistula; VA = vertebral artery.
bral angiography (DSA) revealed a very high-flow 
AVF from the V2 segment of the left VA to the cervical 
venous plexus with a large pseudoaneurysm or venous 
pouch just distal to the fistula (Fig. 2A). Because of 
the high-flow shunt via either antegrade or retrograde 
flow, it seemed impossible to achieve parent artery 
occlusion with coiling only. Thus, short-segment trap-
ping of the left VA was planned and two AVPs (type 
4) were deployed distal and proximal to the fistula 
with coiling between the AVPs (Fig. 2B). As the diam-
eter of the left VA was approximately 3.6 mm, we de-
ployed a 5-mm AVP distally and a 6-mm AVP 
proximally. Finally, the AVF was occluded completely 
(Fig. 2C, D).
DISCUSSION
In the present study, we experienced positive out-
comes with AVPs indicating that these devices could 
be used for therapeutic PAO in the extracranial seg-
ments of the ICA or VA. These devices have a low 
risk of distal migration because they are anchored to 
the vessel wall by radial force. It was recommended 
that oversizing the device by 30-50% with respect to 
the diameter of the parent artery would make the de-
vice more stable. Previously, detachable balloons were 
available to provide a fast method of PAO; however, 
this technique carried the risk of unintentional detach-
ment or early balloon deflation, and distal migration 
of the balloon could lead to recurrence of the disease 
and/or distal thromboembolic complications. In addi-
tion,  the AVP device has multiple layers of cross-sec-
tional nitinol mesh to occlude flow and showed a rap-
id occlusion time, which would prevent the potential 
complications of thrombus formation within the pa-
rent artery and/or distal embolization into the intra-
cranial circulation. With the evolution of endovascular 
techniques and an innovative endovascular approach, 
the management of high-flow vascular lesions in the 
head and neck might be achieved rapidly and safely. 
Moreover, there was a low recurrence rate after suc-
cessful PAO with the AVP.
As mentioned above, the AVP is a self-expanding 
nitinol mesh cage and has been successfully used in 
a wide range of therapeutic applications.14) However, 
relatively few reports about the use of these devices 
 WOOSUNG LEE ET AL
Volume 18 · Number 3 · September 2016  213
in neuroendovascular fields have been published to 
date.6)8-11) The AVP family has evolved from a single 
device to a group of 4 models (types 1 to 4). Type 1 
is a large cylindrical mesh cage and is generally re-
ferred to as the initial model of the AVP family. This 
type is appropriate for short landing zones and has 
high radial force that secures the device within the 
parent vessel. Type 2 is preferred if rapid vessel oc-
clusion is required and is better for minimizing mi-
gration and recanalization compared to type 1. 
Almost all previous reports about the use of AVP in 
neuroendovascular fields involved type 1 and type 2 
AVPs. Type 3 offers a rapid occlusion capability and 
fits elliptical-shaped vascular structures. It is better at 
enhancing stability in high-flow vessels than the pre-
vious types. However, type 3 is not appropriate for 
use in neuroendovascular fields because of its shape 
and radial force. Type 4 is the most effective type if 
the target vessels are small and access to the target 
segments is difficult as it can be delivered using a 
0.038-inch diagnostic catheter without a delivery 
catheter. Type 4 seems to be the most appropriate 
type of AVP for use in neuroendovascular fields. In 
the present series, the AVP type 4 did not move and 
effectively occluded the parent artery proximally as 
well as distally while treating a very high-flow AVF 
(case 10) that migrated coils to a distal venous pouch 
or a pseudoaneurysm. As mentioned above, migration 
is a rare complication of AVP because it is self-ex-
panding and has sufficient radial force on the vessel 
wall to minimize movement.13)
There are some limitations of our study. One limi-
tation is its retrospective design with a very small 
number of included patients. Furthermore, there are 
no control groups for comparison of the effects of the 
AVP with other currently used methods of PAO. 
Another limitation is that there are no follow-up an-
giographic results to show the long-term efficacy of 
the device. However, spontaneous recanalization of 
the AVP after successful PAO is very rare, with only 
5 reports of recurrence among more than 1,200 AVP 
placements described in the literature.1) Regarding 
pulmonary AVMs, 20 published papers have de-
scribed a total of 340 PAOs using AVPs, with re-
currence occurring in approximately 1%.2-4)12) In com-
parison, coil embolization is associated with a re-
currence rate of 8-15%.5)7) In addition, the AVP proce-
dure should be considered a technical failure unless 
complete PAO has been demonstrated. If necessary, 
additional embolic material, such as coils or addi-
tional AVPs, can be used as adjuncts to ensure com-
plete occlusion.
CONCLUSION
Our results in the current series suggest that AVP 
might be used for therapeutic PAO in the extracranial 
segment of the ICA or VA.
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